Trends in treatment and outcomes for acute stroke patients in Ontario, 1992-1998

Archives of Internal Medicine

Volumn 163, Issue 3, 2003, Pages 293-297

  Tu, Jack V ^a,b   Gong, Yanyan ^a  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; STATIN; TICLOPIDINE; WARFARIN;

ADULT; AGED; ARTICLE; CANADA; CAROTID ENDARTERECTOMY; COHORT ANALYSIS; COMORBIDITY; DATA BASE; FEMALE; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; OCCUPATIONAL THERAPY; PHYSIOTHERAPY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SPEECH THERAPY; STROKE; TREATMENT OUTCOME;

ACUTE DISEASE; ADULT; AGED; AGED, 80 AND OVER; ANTICOAGULANTS; CEREBROVASCULAR ACCIDENT; COMORBIDITY; FEMALE; HOSPITAL MORTALITY; HUMANS; LENGTH OF STAY; MALE; MEDICAL RECORD LINKAGE; MIDDLE AGED; ONTARIO; OUTCOME ASSESSMENT (HEALTH CARE); PATIENT DISCHARGE; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; WARFARIN;

EID: 0037429041     PISSN: 00039926     EISSN: None     Source Type: Journal    
DOI: 10.1001/archinte.163.3.293     Document Type: Article

References (17)

1. Canadian Heart and Stroke Surveillance System. The Changing Face of Heart Disease and Stroke in Canada. Ottawa, Ontario: Health Canada; 2000.
2. American Heart Association. 2000 Statistical Update. Dallas, Tex: American Heart Association; 1999.
3. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med. 1995;333:1581-1587.
4. International Stroke Trial Collaborative Group. The International Stroke Trial (IST): a randomised trial of aspirin, subcutaneous heparin, both, or neither among 19 435 patients with acute ischaemic stroke. Lancet. 1997;349:1569-1581.
5. Stroke Unit Trialists' Collaboration. Collaborative systematic review of the randomised trials of organised inpatient (stroke unit) care after stroke. BMJ. 1997;314:1151-1159.
6. Antiplatelet Trialists' Collaboration. Collaborative overview of randomised trials of antiplatelet therapy, I: prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. BMJ. 1994;308:81-106.
7. Hass WK, Easton JD, Adams HP Jr, et al. A randomized trial comparing ticlopidine hydrochloride with aspirin for the prevention of stroke in high-risk patients. N Engl J Med. 1989;321:501-507.
8. Hart RG, Benavente O, McBride R, Pearce LA. Antithrombotic therapy to prevent stroke in patients with atrial fibrillation: a meta-analysis. Ann Intern Med. 1999; 131:492-501.
9. Hebert P, Gaziano JM, Chan KS, Hennekens CH. Cholesterol lowering with statin drugs, risk of stroke, and total mortality: an overview of randomized trials. JAMA. 1997;278:313-321.
10. CAPRIE Steering Committee. A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). Lancet. 1996;348:1329-1339.
11. North American Symptomatic Carotid Endarterectomy Trial Collaborators. Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade carotid stenosis. N Engl J Med. 1991;325:445-453.
12. ICD-9-CM: International Classification of Diseases, Clinical Modification. 9th ed. Los Angeles, Calif: Practice Management Corp; 1998.
13. Canadian Classification of Diagnostic, Therapeutic, and Surgical Procedures. Ontario, Ottawa: Minister of Supply and Services; 1986.
14. Mayo NE, Chockalingam A, Reeder BA, Phillips S. Surveillance for stroke in Canada. Health Rep. 1994;6:62-72.
15. Deyo RA, Cherkin DC, Ciol MA. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol. 1992;45:613-619.
16. SAS Institute. SAS Release 8.0 Software/Computer Program. Cary, NC: SAS Institute Inc; 2000.
17. Tu JV, Porter J. Stroke Care in Ontario: Hospital Survey Results. Toronto, Ontario: Heart and Stroke Foundation of Ontario; 1999.